scispace - formally typeset
S

Samuel R Josephsen

Researcher at Allen Institute for Brain Science

Publications -  5
Citations -  456

Samuel R Josephsen is an academic researcher from Allen Institute for Brain Science. The author has contributed to research in topics: Visual cortex & Dementia. The author has an hindex of 3, co-authored 5 publications receiving 291 citations. Previous affiliations of Samuel R Josephsen include University of Washington.

Papers
More filters
Journal ArticleDOI

Classification of electrophysiological and morphological neuron types in the mouse visual cortex.

TL;DR: A single-cell characterization pipeline is established using standardized patch-clamp recordings in brain slices and biocytin-based neuronal reconstructions to establish a morpho-electrical taxonomy of cell types for the mouse visual cortex via unsupervised clustering analysis of multiple quantitative features.
Journal ArticleDOI

Neuropathological and transcriptomic characteristics of the aged brain.

TL;DR: A comprehensive neuropathological, molecular, and transcriptomic characterization of hippocampus and two regions cortex in 107 aged donors from the Adult Changes in Thought study is generated, highlighting the importance of properly controlling for RNA quality when studying dementia.
Posted ContentDOI

Classification of electrophysiological and morphological types in mouse visual cortex

TL;DR: A taxonomy of morphologically- and electrophysiologically-defined cell types for this region of cortex is established with 17 e-types and 35 m-types, as well as an initial correspondence with previously-defined transcriptomic cell types using the same transgenic mouse lines.
Journal ArticleDOI

Wild-type bone marrow transplant partially reverses neuroinflammation in progranulin-deficient mice.

TL;DR: The results showed that wt bone marrow transplantation (BMT) partially reconstituted progranulin in the periphery and in cerebral cortex of Grn−/− mice and suggest that BMT can be administered as a stem cell-based approach to prevent or to treat neurodegenerative diseases.